Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
7,658,912
-
Share change
-
+1,284,227
-
Total reported value
-
$75,286,748
-
Price per share
-
$9.83
-
Number of holders
-
25
-
Value change
-
+$14,168,314
-
Number of buys
-
13
-
Number of sells
-
7
Institutional Holders of CYMABAY THERAPEUTICS INC - COM (CBAY) as of Q4 2014
As of 31 Dec 2014,
CYMABAY THERAPEUTICS INC - COM (CBAY) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,658,912 shares.
The largest 10 holders included
Lombard Odier Asset Management (USA) Corp, Versant Venture Management, LLC, JENNISON ASSOCIATES LLC, EverPoint Asset Management, LLC, Sectoral Asset Management Inc, Point72 Asset Management, L.P., SPHERA FUNDS MANAGEMENT LTD., ADAGE CAPITAL PARTNERS GP LLC, Visium Asset Management, LP, and VANGUARD GROUP INC.
This page lists
25
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.